BACKGROUND: No study has so far addressed whether differences do exist in the management of cancer pain between patients receiving usual care by primary specialists and those receiving early palliative/supportive intervention.PATIENTS AND METHODS: A multicentre cross-sectional study in 32 Italian Hospitals has included 1450 patients, receiving analgesic therapy for cancer pain: 602 with access to primary specialist alone (standard care, SC) and 848 with early access to a palliative/supportive care (ePSC) team, concomitant with primary oncology care.RESULTS: Statistically significant differences in the analgesic drug administration according to care model have been evident: non-opioids were more frequently used in SC (9.5% versus 2%; P < 0.001), while strong opioids in ePSC group (80% versus 63%; P < 0.001). The number of patients with severe pain was lower in ePSC compared with SC group (31% versus 17%; P < 0.001). Results of multivariate analysis have shown that ePSC integrated with primary oncologic care (relative risk 0.69; 95% confidence interval 0.48-0.99; P = 0.045) was an independent factor associated with a 31% reduced risk of suffering from severe pain.CONCLUSIONS: An ePSC team provides the most effective standard of analgesic therapy for cancer pain. A randomized clinical trial is needed to confirm these findings.

Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer / Bandieri, E; Sichetti, D; Romero, M; Fanizza, C; Belfiglio, M; Buonaccorso, L; Artioli, F; Campione, F; Tognoni, G; Luppi, Mario. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - STAMPA. - 8:(2012), pp. 2016-2020. [10.1093/annonc/mds103]

Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer.

LUPPI, Mario
2012

Abstract

BACKGROUND: No study has so far addressed whether differences do exist in the management of cancer pain between patients receiving usual care by primary specialists and those receiving early palliative/supportive intervention.PATIENTS AND METHODS: A multicentre cross-sectional study in 32 Italian Hospitals has included 1450 patients, receiving analgesic therapy for cancer pain: 602 with access to primary specialist alone (standard care, SC) and 848 with early access to a palliative/supportive care (ePSC) team, concomitant with primary oncology care.RESULTS: Statistically significant differences in the analgesic drug administration according to care model have been evident: non-opioids were more frequently used in SC (9.5% versus 2%; P < 0.001), while strong opioids in ePSC group (80% versus 63%; P < 0.001). The number of patients with severe pain was lower in ePSC compared with SC group (31% versus 17%; P < 0.001). Results of multivariate analysis have shown that ePSC integrated with primary oncologic care (relative risk 0.69; 95% confidence interval 0.48-0.99; P = 0.045) was an independent factor associated with a 31% reduced risk of suffering from severe pain.CONCLUSIONS: An ePSC team provides the most effective standard of analgesic therapy for cancer pain. A randomized clinical trial is needed to confirm these findings.
2012
8
2016
2020
Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer / Bandieri, E; Sichetti, D; Romero, M; Fanizza, C; Belfiglio, M; Buonaccorso, L; Artioli, F; Campione, F; Tognoni, G; Luppi, Mario. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - STAMPA. - 8:(2012), pp. 2016-2020. [10.1093/annonc/mds103]
Bandieri, E; Sichetti, D; Romero, M; Fanizza, C; Belfiglio, M; Buonaccorso, L; Artioli, F; Campione, F; Tognoni, G; Luppi, Mario
File in questo prodotto:
File Dimensione Formato  
PIIS0923753419381219.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 106.69 kB
Formato Adobe PDF
106.69 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/740812
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 56
  • ???jsp.display-item.citation.isi??? 49
social impact